Adult Acute Myeloid Leukemia Clinical Trial
Official title:
Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Mocravimod as Adjunctive and Maintenance Treatment in Adult AML Patients Undergoing Allogeneic HCT
This is a multi-center, randomized, double-blinded, placebo controlled trial.
The purpose of this study is to evaluate the efficacy and safety of mocravimod as an adjunctive and maintenance treatment in adult acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic cell transplantation (HCT). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01146223 -
Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia
|
N/A | |
| Completed |
NCT01295710 -
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
|
Phase 3 | |
| Completed |
NCT01807091 -
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
|
N/A | |
| Recruiting |
NCT03114670 -
Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT
|
Phase 1 | |
| Active, not recruiting |
NCT03226418 -
Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia
|
Phase 2 | |
| Recruiting |
NCT05262465 -
Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML
|
N/A | |
| Recruiting |
NCT06329999 -
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
|
N/A | |
| Completed |
NCT01484015 -
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
|
Phase 1 | |
| Completed |
NCT01041443 -
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
|
Phase 1 | |
| Not yet recruiting |
NCT03283228 -
Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia
|
N/A | |
| Completed |
NCT01251575 -
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
|
Phase 2 | |
| Recruiting |
NCT06045819 -
Relation Between Venetoclax Plasma Concentration and Remission in Adults With Acute Myeloid Leukemia (PREDICLAX)
|
||
| Withdrawn |
NCT00101140 -
Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
|
Phase 2 |